A Deeper Shade of Blue

Depression is common during pregnancy, affecting 10% to 15% of women.  While psychotherapy is an attractive option for the treatment of depression during pregnancy, all women do not respond to this intervention and many require pharmacotherapy.  Thus far, no antidepressants have yet been approved by the FDA for use during pregnancy. Although data accumulated over […]

About 10% to 15% of women suffer from depression during pregnancy.  Literature accumulated over the last decade supports the use of certain selective serotonin reuptake inhibitors (SSRIs) and the older tricyclic antidepressants during pregnancy, indicating no overall increase in the risk of congenital malformation in children exposed to these medications during the first trimester of […]

Literature accumulated over the last decade supports the use of certain selective serotonin reuptake inhibitors (SSRIs) and the older tricyclic antidepressants during pregnancy, indicating no overall increase in the risk of congenital malformation in children exposed to these medications during the first trimester of pregnancy. Still, questions remain regarding the reproductive safety of SSRIs, including […]

There are many studies which support the use of certain antidepressants during pregnancy. Most of the research over the last decade has focused on the selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac) and the older tricyclic antidepressants but there is some new data supporting the use of bupropion (Wellbutrin) during pregnancy.
Earlier reports had revealed […]